Cargando…

Preparation of chemically stable allergen‐specific sublingual immunotherapy from Egyptian allergens

BACKGROUND: The term “allergen extracts” refers to solutions of proteins or glycoproteins extracted from source raw materials. OBJECTIVES: This study was planned to prepare chemically stable sublingual immunotherapy from different allergens in Egypt. METHODS: Allergen extraction from raw materials....

Descripción completa

Detalles Bibliográficos
Autores principales: Abu El‐Enin, Mohammed A., Rabie Shehab El‐Din, Eman M., Abdelwahab, Heba Wagih, Abd El‐Maksoud, Amina, Abd El‐Aziz, Abeer M., Shaaban, Mona I., Attia, Ahmed Nader, Aboukamar, Wafaa A., Mohei‐Aldin, Sanaa, Belal, Fathalla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906013/
https://www.ncbi.nlm.nih.gov/pubmed/35150027
http://dx.doi.org/10.1002/jcla.24261
_version_ 1784665312173490176
author Abu El‐Enin, Mohammed A.
Rabie Shehab El‐Din, Eman M.
Abdelwahab, Heba Wagih
Abd El‐Maksoud, Amina
Abd El‐Aziz, Abeer M.
Shaaban, Mona I.
Attia, Ahmed Nader
Aboukamar, Wafaa A.
Mohei‐Aldin, Sanaa
Belal, Fathalla
author_facet Abu El‐Enin, Mohammed A.
Rabie Shehab El‐Din, Eman M.
Abdelwahab, Heba Wagih
Abd El‐Maksoud, Amina
Abd El‐Aziz, Abeer M.
Shaaban, Mona I.
Attia, Ahmed Nader
Aboukamar, Wafaa A.
Mohei‐Aldin, Sanaa
Belal, Fathalla
author_sort Abu El‐Enin, Mohammed A.
collection PubMed
description BACKGROUND: The term “allergen extracts” refers to solutions of proteins or glycoproteins extracted from source raw materials. OBJECTIVES: This study was planned to prepare chemically stable sublingual immunotherapy from different allergens in Egypt. METHODS: Allergen extraction from raw materials. The concentrated aqueous extract of each allergen was mixed with an equal volume of glycerol. The protein content of the preparations was determined using the modified Lowry assay method. The prepared allergens were stored for 9 months at 2–4°C. Samples were analyzed periodically (0, 3, 6, and 9 months of intervals) adopting the Lowry Assay method. Levels of specific IgE to Chenopodium album antigens were measured in patients’ sera by ELISA. RESULTS: The concentration of all prepared allergens, as indicated by the concentration of the protein content, was found to decrease exponentially with time, implying first‐order kinetics of degradation. From the values of the slopes of the log plot for each allergen, the half‐life time (t (1/2)) and (t (1/4)) values were calculated. The expiration date was considered as the time after which the allergen loses 25% of its potency. The obtained values of t (1/4%) vary according to the type of vaccine. The most stable one is that of Chenopodium album pollens (2.4 years) and the least stable is that of house dust Mites (9 months). The immunological characters of Chenopodium album extract were stable for at least 6 months. CONCLUSION: Differences exist among allergen extracts made by multiple manufacturers. So, developments in studies on allergen preparation and characterization in a different locality are necessary.
format Online
Article
Text
id pubmed-8906013
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-89060132022-03-10 Preparation of chemically stable allergen‐specific sublingual immunotherapy from Egyptian allergens Abu El‐Enin, Mohammed A. Rabie Shehab El‐Din, Eman M. Abdelwahab, Heba Wagih Abd El‐Maksoud, Amina Abd El‐Aziz, Abeer M. Shaaban, Mona I. Attia, Ahmed Nader Aboukamar, Wafaa A. Mohei‐Aldin, Sanaa Belal, Fathalla J Clin Lab Anal Research Articles BACKGROUND: The term “allergen extracts” refers to solutions of proteins or glycoproteins extracted from source raw materials. OBJECTIVES: This study was planned to prepare chemically stable sublingual immunotherapy from different allergens in Egypt. METHODS: Allergen extraction from raw materials. The concentrated aqueous extract of each allergen was mixed with an equal volume of glycerol. The protein content of the preparations was determined using the modified Lowry assay method. The prepared allergens were stored for 9 months at 2–4°C. Samples were analyzed periodically (0, 3, 6, and 9 months of intervals) adopting the Lowry Assay method. Levels of specific IgE to Chenopodium album antigens were measured in patients’ sera by ELISA. RESULTS: The concentration of all prepared allergens, as indicated by the concentration of the protein content, was found to decrease exponentially with time, implying first‐order kinetics of degradation. From the values of the slopes of the log plot for each allergen, the half‐life time (t (1/2)) and (t (1/4)) values were calculated. The expiration date was considered as the time after which the allergen loses 25% of its potency. The obtained values of t (1/4%) vary according to the type of vaccine. The most stable one is that of Chenopodium album pollens (2.4 years) and the least stable is that of house dust Mites (9 months). The immunological characters of Chenopodium album extract were stable for at least 6 months. CONCLUSION: Differences exist among allergen extracts made by multiple manufacturers. So, developments in studies on allergen preparation and characterization in a different locality are necessary. John Wiley and Sons Inc. 2022-02-11 /pmc/articles/PMC8906013/ /pubmed/35150027 http://dx.doi.org/10.1002/jcla.24261 Text en © 2022 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Abu El‐Enin, Mohammed A.
Rabie Shehab El‐Din, Eman M.
Abdelwahab, Heba Wagih
Abd El‐Maksoud, Amina
Abd El‐Aziz, Abeer M.
Shaaban, Mona I.
Attia, Ahmed Nader
Aboukamar, Wafaa A.
Mohei‐Aldin, Sanaa
Belal, Fathalla
Preparation of chemically stable allergen‐specific sublingual immunotherapy from Egyptian allergens
title Preparation of chemically stable allergen‐specific sublingual immunotherapy from Egyptian allergens
title_full Preparation of chemically stable allergen‐specific sublingual immunotherapy from Egyptian allergens
title_fullStr Preparation of chemically stable allergen‐specific sublingual immunotherapy from Egyptian allergens
title_full_unstemmed Preparation of chemically stable allergen‐specific sublingual immunotherapy from Egyptian allergens
title_short Preparation of chemically stable allergen‐specific sublingual immunotherapy from Egyptian allergens
title_sort preparation of chemically stable allergen‐specific sublingual immunotherapy from egyptian allergens
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906013/
https://www.ncbi.nlm.nih.gov/pubmed/35150027
http://dx.doi.org/10.1002/jcla.24261
work_keys_str_mv AT abueleninmohammeda preparationofchemicallystableallergenspecificsublingualimmunotherapyfromegyptianallergens
AT rabieshehabeldinemanm preparationofchemicallystableallergenspecificsublingualimmunotherapyfromegyptianallergens
AT abdelwahabhebawagih preparationofchemicallystableallergenspecificsublingualimmunotherapyfromegyptianallergens
AT abdelmaksoudamina preparationofchemicallystableallergenspecificsublingualimmunotherapyfromegyptianallergens
AT abdelazizabeerm preparationofchemicallystableallergenspecificsublingualimmunotherapyfromegyptianallergens
AT shaabanmonai preparationofchemicallystableallergenspecificsublingualimmunotherapyfromegyptianallergens
AT attiaahmednader preparationofchemicallystableallergenspecificsublingualimmunotherapyfromegyptianallergens
AT aboukamarwafaaa preparationofchemicallystableallergenspecificsublingualimmunotherapyfromegyptianallergens
AT moheialdinsanaa preparationofchemicallystableallergenspecificsublingualimmunotherapyfromegyptianallergens
AT belalfathalla preparationofchemicallystableallergenspecificsublingualimmunotherapyfromegyptianallergens